HCPLive

Top Medical News Today

Christoph Koenen from Bristol-Myers Squibb: The Value of Real-World Data on Eliquis Research
Emerging more frequently as part of the total evidence generated with Eliquis, real-world data allows researchers to work with larger populations to show specific reductions in major bleeding and stroke, as well.
Dormant viruses dodge the immune system, and although these viruses don’t actively replicate, the problem is that they also don’t produce a chemical signal which would tell the antiretroviral therapy (ART) to attack them.
Retrospective study results indicate that golimumab may be a new and effective choice for maintaining remission and preventing recurrence of severe, recurrent anterior uveitis in patients with HLA-B27-positive ankylosing spondylitis.
A long-acting fluocinolone acetonide implant improved visual acuity and controlled intraocular inflammation for 2 years in 11 eyes of 11 patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis.
Because of the potentially devastating neurologic consequences of syphilis, this sexually transmitted disease should be considered in all patients who initially appear with uveitis.
Adverse side effects are a potential risk with nearly every medication, so scientists from the University of Oxford in England looked at if this phenomenon occurs in common drugs that are used to treat the human immunodeficiency virus (HIV).
As people's lives get busy one of the things that suffers the most is their ability to get the proper amount of sleep. This can range from mild sleep issues to more extensive bouts of insomnia.
For patients who struggle with positive airway pressure machines there have been developments in recent years to help them treat their sleep apnea and other disorders.
Whether it is obstructive or central sleep apnea or any number of other conditions finding the right treatment method can make a big difference in improving quality of life.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$